TechWald Holding
Turin, Piedmonttechwald.com
Overview
Techwald Holding S.p.A. has relevant expertise in supporting the growth of potential early stage companies committed to develop healthcare innovation with a focus on MedTech Industry and Medical Technologies. The Company's purpose is the performance of services and managerial activities for the strategic orientation, development, support, coordination and management of shareholdings acquired as stable equity investments in the sector of HealthCare/MedTech – Pharma/Biotech.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| RapidPulse | Jul 2026 | Series B | Lead |
| Nitinotes Ltd. | Dec 2024 | SAFE | Co-investor |
| Lymphatica Medtech SA | Oct 2024 | Series B | Lead |
| SentiAR | Apr 2023 | Series B | Co-investor |
| SoniVie | Jan 2023 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
